Accelerate biomedical R&D

Promising science does not always translate into a blockbuster

Translating a promising discovery into a new drug or therapy is a costly, lengthy and risky process, with an average cost of $2.3 billion and an average development time of 15 years.

One of the key factors influencing this process is target identification and validation. Advanced IT solutions and Artificial Intelligence (AI) are playing a transformative role in drug discovery and development by accelerating processes, enhancing efficiency and enabling novel approaches.


Time to bring a drug to the market


The average R&D investment


High attrition rate results in only 10% of drugs reaching the market